- Home
- VNDA vs FVCB Comparison
VNDA vs FVCB Comparison
Compare VNDA & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FVCB
- Stock Information
- Founded
- VNDA 2002
- FVCB 2007
- Country
- VNDA United States
- FVCB United States
- Employees
- VNDA N/A
- FVCB N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FVCB Major Banks
- Sector
- VNDA Health Care
- FVCB Finance
- Exchange
- VNDA Nasdaq
- FVCB Nasdaq
- Market Cap
- VNDA 257.8M
- FVCB 248.5M
- IPO Year
- VNDA 2006
- FVCB N/A
- Fundamental
- Price
- VNDA $4.43
- FVCB $11.05
- Analyst Decision
- VNDA Strong Buy
- FVCB
- Analyst Count
- VNDA 2
- FVCB 0
- Target Price
- VNDA $16.50
- FVCB N/A
- AVG Volume (30 Days)
- VNDA 640.7K
- FVCB 14.9K
- Earning Date
- VNDA 02-13-2025
- FVCB 01-23-2025
- Dividend Yield
- VNDA N/A
- FVCB N/A
- EPS Growth
- VNDA N/A
- FVCB 290.48
- EPS
- VNDA N/A
- FVCB 0.82
- Revenue
- VNDA $198,772,000.00
- FVCB $58,117,000.00
- Revenue This Year
- VNDA $16.07
- FVCB N/A
- Revenue Next Year
- VNDA $24.42
- FVCB N/A
- P/E Ratio
- VNDA N/A
- FVCB $14.20
- Revenue Growth
- VNDA 3.18
- FVCB 42.12
- 52 Week Low
- VNDA $3.71
- FVCB $9.78
- 52 Week High
- VNDA $6.75
- FVCB $14.50
- Technical
- Relative Strength Index (RSI)
- VNDA 44.53
- FVCB 35.78
- Support Level
- VNDA $4.34
- FVCB $12.22
- Resistance Level
- VNDA $4.65
- FVCB $12.41
- Average True Range (ATR)
- VNDA 0.21
- FVCB 0.42
- MACD
- VNDA -0.01
- FVCB -0.09
- Stochastic Oscillator
- VNDA 36.51
- FVCB 1.57
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.